About Elara Pharmaceuticals
The Heidelberg-based biotech company ELARA Pharmaceuticals is developing compounds for the treatment of cancer that both inhibit the hypoxia signaling pathway and induce apoptosis. The most advanced drug candidate is directed against multiple myeloma, a malignant disease of the plasma cells of the immune system.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Facts about Elara Pharmaceuticals
Facts about Elara Pharmaceuticals
- Focus : Manufacturer
- Industry : Pharma
